Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Manhattan Associates Inc Surpasses Expectations and Receives Positive Analyst Ratings

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
ESG Ratings: A New Benchmark for Textile Companies
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On January 31, 2024, Manhattan Associates, Inc. (NASDAQ: MANH) delivered impressive fourth-quarter results, surpassing market expectations. The company reported adjusted earnings of $1.03 per share, exceeding the estimated 80 cents per share. Quarterly sales reached $238.25 million, surpassing the anticipated $223.97 million. This outstanding performance prompted analysts to revise their price targets for Manhattan Associates.

Rosenblatt raised their price target from $215 to $225 while maintaining a Neutral rating. Similarly, Raymond James increased their price target from $214 to $250, maintaining an Outperform rating. The average price target from three Wall Street analysts stands at $242.50, with a high forecast of $245.00.

In another positive development, StockNews.com upgraded Manhattan Associates’ shares from a “hold” rating to a “buy” rating. As a result, the company’s shares experienced a significant surge of 10.8% in pre-market trading, reaching $248.00.

Overall, Manhattan Associates’ exceptional performance and positive market sentiment highlight its strong position in the industry.

Manhattan Associates Inc. (MANH) Stock Surges with Impressive Price Increase and Positive Momentum

On January 31, 2024, Manhattan Associates Inc. (MANH) experienced a significant surge in its stock performance. The company’s stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating a positive trend in its price momentum.

One of the key factors contributing to this remarkable performance was the price change observed on this day. MANH shares witnessed an impressive increase of $16.53 since the market last closed, representing a rise of 7.39%. This surge in price demonstrates the strong investor confidence and market demand for the company’s stock.

The day began on a positive note for MANH, with the stock opening at $255.65. This opening price was $31.87 higher than its previous close, indicating a significant gap up in the stock’s value.

Trading near the top of its 52-week range suggests that MANH has been performing well over the past year and has managed to maintain a positive trajectory. This indicates that the company has been able to generate consistent value for its shareholders and has attracted investor interest.

Moreover, being above its 200-day simple moving average indicates that MANH’s stock has exhibited a positive trend over a longer time frame. This moving average is a widely used technical indicator that helps investors identify the overall direction of a stock’s price movement. The fact that MANH is trading above this average suggests that the stock has been on an upward trajectory for a considerable period.

Investors and market participants should take note of MANH’s impressive stock performance on January 31, 2024. The significant price increase, coupled with trading near the top of its 52-week range and above its 200-day simple moving average, indicates a strong positive sentiment surrounding the company. However, it is essential to conduct thorough research and analysis before making any investment decisions, as stock performance can be influenced by various factors and may fluctuate in the future.

Manhattan Associates Inc Reports Positive Results with Steady Growth and Profitability

MANH stock, representing the performance of Manhattan Associates Inc, showed positive results on January 31, 2024. The company’s total revenue for the past year was $928.73 million, with a quarterly revenue of $238.25 million. Comparing these figures to the previous year, there has been a 21.07% increase in total revenue. However, the total revenue remained flat since the last quarter.

The net income for Manhattan Associates Inc was $176.57 million for the past year, with a quarterly net income of $48.74 million. This indicates a significant increase of 36.92% in net income compared to the previous year. However, similar to the total revenue, the net income remained unchanged since the last quarter.

The earnings per share (EPS) for the company were $2.82 for the past year, with a quarterly EPS of $0.78. This reflects a remarkable increase of 38.66% in EPS compared to the previous year. However, like total revenue and net income, the EPS remained flat since the last quarter.

These positive financial indicators suggest that Manhattan Associates Inc has experienced steady growth and profitability over the past year. The increase in total revenue, net income, and EPS showcases the company’s ability to generate higher profits and deliver value to its shareholders.

Tags: MANH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Anticipation Builds for United States Steels Fourth Quarter Earnings

Navigating Legal Battles: A Deep Dive into High-Stakes Cryptocurrency Disputes

Impending Quarterly Earnings Report and Stock Price Impact for Merck Co

Renewable energy

Analyzing Shells Earnings Report and Stock Performance

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com